In today's episode, Adam Rose (@adjoro) & Dr. Alok Patel (@alokpatelmd) cover the FDA's landmark approval of Moderna's first mRNA flu vaccine for adults. They break down the phase-three trial showing the mRNA shot produced fewer confirmed influenza cases than standard vaccines, and what a complicated insurance landscape means for access this flu season. Plus: researchers at the Arc Institute fed millions of viral DNA sequences to a language model. It wrote new genomes that had never existed in nature, and sixteen of them came to life in the lab. Then, they look at a new narcolepsy drug targeting the underlying orexin deficiency, a Salmonella outbreak linked to jalapeños spreading through 27 states, and over 2,400 measles cases putting U.S. elimination status in jeopardy.
(0:00) Intro
(1:01) First mRNA Flu Vaccine Approved
(4:52) AI Designs Functional Viruses
(8:54) Salmonella Jalapeño Outbreak
(9:44) Measles Resurgence
(10:04) Women's Pro Baseball
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com.
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Podden och tillhörande omslagsbild på den här sidan tillhör
Human Content, Inc.. Innehållet i podden är skapat av Human Content, Inc. och inte av,
eller tillsammans med, Poddtoppen.
